Table 2.
SCZ |
Controls |
|||
---|---|---|---|---|
Variable | R | p | R | p |
pH | −0.034 | 0.818 | 0.024 | 0.879 |
PMI | 0.163 | 0.273 | 0.023 | 0.884 |
BMI | −0.036 | 0.818 | 0.243 | 0.121 |
Age of Onset | −0.01 | 0.989 | N.A. | N.A. |
Duration of Illness | 0.11 | 0.499 | N.A. | N.A. |
Age at Death | 0.035 | 0.817 | −0.273 | 0.076 |
Brain Weight | 0.204 | 0.169 | 0.114 | 0.467 |
Freezer Storage Time | 0 | 0.998 | −0.121 | 0.465 |
Age at First Hospitalization | 0.02 | 0.915 | N.A. | N.A. |
Median CPZE | −0.15 | 0.341 | N.A. | N.A. |
Cumulative Lifetime CPZE | −0.3 | 0.051 | N.A. | N.A. |
Last Known CPZE | −0.25 | 0.147 | N.A. | N.A. |
t |
p |
t |
p |
|
Smoking Status | 0.94 | 0.352 | 0.422 | 0.675 |
Gender | 0.108 | 0.915 | 0.154 | 0.879 |
Comorbid Alcohol Abuse/ Dependence | 0.28 | 0.780 | N.A. | N.A. |
Comorbid Substance Abuse/ Dependence | 0.47 | 0.642 | N.A. | N.A. |
Antipsychotic drugs in brain at autopsy | −0.46 | 0.646 | N.A. | N.A. |
Nicotine in brain at autopsy | −0.23 | 0.823 | 0.70 | 0.489 |
Cotinine in brain at autopsy | −1.30 | 0.200 | 0.56 | 0.581 |
Gender | 0.108 | 0.915 | 0.154 | 0.879 |
BMI: body mass index; CPZE: chlorpromazine equivalents; PMI: postmortem interval